tert-Butyl 3-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl)pyrrolidine-1-carboxylate

Catalog No. :
ACROFX048
CAS No. :
2223006-38-8
Molecular Formula :
C18H29BN2O4S
Molecular Weight :
380.32

IUPAC Name:tert-butyl 3-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl)pyrrolidine-1-carboxylate

tert-Butyl 3-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl)pyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl)pyrrolidine-1-carboxylate
IUPAC Nametert-butyl 3-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl)pyrrolidine-1-carboxylate
Molecular FormulaC18H29BN2O4S
Molecular Weight380.32
SMILESO=C(N1CC(C2=NC=C(B3OC(C)(C)C(C)(C)O3)S2)CC1)OC(C)(C)C
InChI KeySDZOCKDFMMGPNK-UHFFFAOYSA-N
Synonymtert-butyl 3-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiazol-2-yl)pyrrolidine-1-carboxylate;1-Pyrrolidinecarboxylic acid, 3-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-thiazolyl]-, 1,1-dimethylethyl ester
CAS No.2223006-38-8

Synthetic Route by SureRoute

1. ACROFX048 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACROFX048 route product structure diagram
    ACROFX0482223006-38-8
Inquiry

2. ACROFX048 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZKSG345 route compound structure diagram
    ACZKSG345774234-25-2 In Stock
  2. Plus
  3. ACMPUC634 route compound structure diagram
    ACMPUC6341402166-32-8 In Stock
  4. Then
  5. ACROFX048 route product structure diagram
    ACROFX0482223006-38-8
Inquiry

Comments (0)